Exicure (XCUR) Competitors

Inventiva (NASDAQ:IVA) and Exicure (NASDAQ:XCUR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

Do analysts prefer IVA or XCUR?

Inventiva currently has a consensus target price of $13.25, indicating a potential upside of 438.40%. Given Inventiva's stronger consensus rating and higher possible upside, analysts clearly believe Inventiva is more favorable than Exicure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inventiva	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Exicure	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has higher valuation and earnings, IVA or XCUR?

Exicure has higher revenue and earnings than Inventiva.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inventiva	$18.91M	6.83	-$119.51M	N/A	N/A
Exicure	$28.83M	1.02	-$16.91M	-$2.07	-5.43

Does the media favor IVA or XCUR?

In the previous week, Inventiva had 2 more articles in the media than Exicure. MarketBeat recorded 6 mentions for Inventiva and 4 mentions for Exicure. Exicure's average media sentiment score of 0.88 beat Inventiva's score of 0.49 indicating that Exicure is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inventiva	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Exicure	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Is IVA or XCUR more profitable?

Inventiva's return on equity of 0.00% beat Exicure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inventiva	N/A	N/A	N/A
Exicure	N/A	-190.90%	-36.75%

Does the MarketBeat Community prefer IVA or XCUR?

Inventiva received 12 more outperform votes than Exicure when rated by MarketBeat users. Likewise, 80.77% of users gave Inventiva an outperform vote while only 47.37% of users gave Exicure an outperform vote.

Company	Underperform	Outperform
Inventiva	Outperform Votes 21 80.77%	Underperform Votes 5 19.23%
Exicure	Outperform Votes 9 47.37%	Underperform Votes 10 52.63%

Which has more risk and volatility, IVA or XCUR?

Inventiva has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, Exicure has a beta of 3.81, indicating that its stock price is 281% more volatile than the S&P 500.

Do institutionals & insiders hold more shares of IVA or XCUR?

19.1% of Inventiva shares are held by institutional investors. Comparatively, 42.8% of Exicure shares are held by institutional investors. 32.0% of Inventiva shares are held by company insiders. Comparatively, 3.9% of Exicure shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Inventiva beats Exicure on 10 of the 15 factors compared between the two stocks.